0000950170-23-032034.txt : 20230706 0000950170-23-032034.hdr.sgml : 20230706 20230706163037 ACCESSION NUMBER: 0000950170-23-032034 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230703 FILED AS OF DATE: 20230706 DATE AS OF CHANGE: 20230706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mullins Kevin Michael CENTRAL INDEX KEY: 0001864233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40478 FILM NUMBER: 231073993 MAIL ADDRESS: STREET 1: 4800 N. SCOTTSDALE ROAD STREET 2: SUITE 6000 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LifeStance Health Group, Inc. CENTRAL INDEX KEY: 0001845257 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4800 N. SCOTTSDALE ROAD STREET 2: SUITE 6000 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 BUSINESS PHONE: 602-767-2100 MAIL ADDRESS: STREET 1: 4800 N. SCOTTSDALE ROAD STREET 2: SUITE 6000 CITY: SCOTTSDALE STATE: AZ ZIP: 85251 4 1 ownership.xml 4 X0407 4 2023-07-03 0001845257 LifeStance Health Group, Inc. LFST 0001864233 Mullins Kevin Michael C/O LIFESTANCE HEALTH GROUP, INC. 4800 N. SCOTTSDALE ROAD, SUITE 6000 SCOTTSDALE AZ 85251 false true false false Chief Development Officer false Common Stock 2023-07-03 4 S false 54600 9.00 D 5316016 D Common Stock 2023-07-05 4 S false 150000 8.72 D 5166016 D The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.91 to $9.13 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $8.63 to $8.96 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. By: /s/ Ryan Pardo, Attorney-in-Fact 2023-07-06